Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis of SLE requires extensive testing due to its complex symptoms.

Managing severe infections in SLE patients requires tailored treatment strategies.

Azelaic acid's effectiveness in treating certain skin conditions needs more research.

People with weakened immune systems, like those with SLE, are at higher risk for TB.

The combination therapy was effective and well-tolerated, especially in young patients.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

The man's rash, hair loss, and vision issues were due to syphilis, not CMV.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Combining ciclosporin and simvastatin can cause severe kidney damage.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.